The ubiquitin/proteasome system-dependent control of mitochondrial steps in apoptosis

Seminars in Cell and Developmental Biology

Volumn 23, Issue 5, 2012, Pages 499-508

  Neutzner, Albert ^a   Li, Sunan ^b   Xu, Shan ^b   Karbowski, Mariusz ^b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Bcl 2; E3 ubiquitin ligase; Mitochondria; Proteasome; Ubiquitin

Indexed keywords

BCL2 RELATED PROTEIN A1; BIM PROTEIN; CASPASE; ENZYME; PROTEASOME; PROTEIN; PROTEIN ARTS; PROTEIN BAD; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL W; PROTEIN BCL XL; PROTEIN BLK; PROTEIN BMF; PROTEIN MCL 1; PROTEIN MOAP 1; PROTEIN NOXA; PUMA PROTEIN; UBIQUITIN; UBIQUITIN ACTIVATING ENZYME E1; UBIQUITIN CONJUGATING ENZYME E2; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

APOPTOSIS; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; INTRACELLULAR SIGNALING; MAMMAL CELL; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; NONHUMAN; PROTEIN DEGRADATION; PROTEIN STABILITY; REVIEW; TRANSCRIPTION REGULATION; UBIQUITINATION;

MAMMALIA;

EID: 84863880821     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2012.03.019     Document Type: Review

References (108)

1. Ciechanover A., Elias S., Heller H., Ferber S., Hershko A. Characterization of the heat-stable polypeptide of the ATP-dependent proteolytic system from reticulocytes. Journal of Biological Chemistry 1980, 255:7525-7528.
2. Hershko A., Ciechanover A. The ubiquitin system for protein degradation. Annual Review of Biochemistry 1992, 61:761-807.
3. Hershko A., Ciechanover A. The ubiquitin system. Annual Review of Biochemistry 1998, 67:425-479.
4. Millard S.M., Wood S.A. Riding the DUBway: regulation of protein trafficking by deubiquitylating enzymes. Journal of Cell Biology 2006, 173:463-468.
5. Reyes-Turcu F.E., Ventii K.H., Wilkinson K.D. Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annual Review of Biochemistry 2009, 78:363-397.
6. Frappier L., Verrijzer C.P. Gene expression control by protein deubiquitinases. Current Opinion in Genetics and Development 2011, 21:207-213.
7. Welchman R.L., Gordon C., Mayer R.J. Ubiquitin and ubiquitin-like proteins as multifunctional signals. Nature Reviews Molecular Cell Biology 2005, 6:599-609.
8. Staub O., Rotin D. Role of ubiquitylation in cellular membrane transport. Physiological Reviews 2006, 86:669-707.
9. Sun L., Chen Z.J. The novel functions of ubiquitination in signaling. Current Opinion in Cell Biology 2004, 16:119-126.
10. Tanaka A., Cleland M.M., Xu S., Narendra D.P., Suen D.F., Karbowski M., et al. Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. Journal of Cell Biology 2010, 191:1367-1380.
11. Pines J., Lindon C. Proteolysis: anytime, any place, anywhere?. Nature Cell Biology 2005, 7:731-735.
12. Neutzner A., Neutzner M., Benischke A.S., Ryu S.W., Frank S., Youle R.J., et al. A systematic search for ER membrane-associated RING finger proteins identifies Nixin/ZNRF4 as a regulator of calnexin stability and ER homeostasis. Journal of Biological Chemistry 2011.
13. Karbowski M., Youle R.J. Regulating mitochondrial outer membrane proteins by ubiquitination and proteasomal degradation. Current Opinion in Cell Biology 2011, 23:476-482.
14. Vaux D.L., Silke J. IAPs, RINGs and ubiquitylation. Nature Reviews Molecular Cell Biology 2005, 6:287-297.
15. Salvesen G.S., Duckett C.S. IAP proteins: blocking the road to death's door. Nature Reviews Molecular Cell Biology 2002, 3:401-410.
16. Broemer M., Meier P. Ubiquitin-mediated regulation of apoptosis. Trends in Cell Biology 2009, 19:130-140.
17. Zhang H.G., Wang J., Yang X., Hsu H.C., Mountz J.D. Regulation of apoptosis proteins in cancer cells by ubiquitin. Oncogene 2004, 23:2009-2015.
18. Chipuk J.E., Green D.R. How do BCL-2 proteins induce mitochondrial outer membrane permeabilization?. Trends in Cell Biology 2008, 18:157-164.
19. Youle R.J., Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nature Reviews Molecular Cell Biology 2008, 9:47-59.
20. Strasser A., Cory S., Adams J.M. Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases. EMBO Journal 2011, 30:3667-3683.
21. Crawford E.D., Wells J.A. Caspase substrates and cellular remodeling. Annual Review of Biochemistry 2011, 80:1055-1087.
22. Morizane Y., Honda R., Fukami K., Yasuda H. X-linked inhibitor of apoptosis functions as ubiquitin ligase toward mature caspase-9 and cytosolic Smac/DIABLO. Journal of Biochemistry 2005, 137:125-132.
23. Wilson R., Goyal L., Ditzel M., Zachariou A., Baker D.A., Agapite J., et al. The DIAP1 RING finger mediates ubiquitination of Dronc and is indispensable for regulating apoptosis. Nature Cell Biology 2002, 4:445-450.
24. Schile A.J., Garcia-Fernandez M., Steller H. Regulation of apoptosis by XIAP ubiquitin-ligase activity. Genes and Development 2008, 22:2256-2266.
25. Adams J.M., Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 2007, 26:1324-1337.
26. Zhong Q., Gao W., Du F., Wang X. Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 2005, 121:1085-1095.
27. Inuzuka H., Shaik S., Onoyama I., Gao D., Tseng A., Maser R.S., et al. SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction. Nature 2011, 471:104-109.
28. Schwickart M., Huang X., Lill J.R., Liu J., Ferrando R., French D.M., et al. Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival. Nature 2010, 463:103-107.
29. Cuconati A., Mukherjee C., Perez D., White E. DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells. Genes and Development 2003, 17:2922-2932.
30. Nijhawan D., Fang M., Traer E., Zhong Q., Gao W., Du F., et al. Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes and Development 2003, 17:1475-1486.
31. Xu S., Peng G., Wang Y., Fang S., Karbowski M. The AAA-ATPase p97 is essential for outer mitochondrial membrane protein turnover. Molecular Biology of the Cell 2011, 22:291-300.
32. Warr M.R., Acoca S., Liu Z., Germain M., Watson M., Blanchette M., et al. BH3-ligand regulates access of MCL-1 to its E3 ligase. FEBS Letters 2005, 579:5603-5608.
33. Ye Y., Meyer H., Rapoport T. The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol. Nature 2001, 414:652-656.
34. Ye Y., Shibata Y., Yun C., Ron D., Rapoport T.A. A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature 2004, 429:841-847.
35. Jentsch S., Rumpf S. Cdc48 (p97): a "molecular gearbox" in the ubiquitin pathway?. Trends in Biochemical Sciences 2007, 32:6-11.
36. Halawani D., Latterich M. p97: The cell's molecular purgatory?. Molecular Cell 2006, 22:713-717.
37. Azad N., Vallyathan V., Wang L., Tantishaiyakul V., Stehlik C., Leonard S.S., et al. S-nitrosylation of Bcl-2 inhibits its ubiquitin-proteasomal degradation. A novel antiapoptotic mechanism that suppresses apoptosis. Journal of Biological Chemistry 2006, 281:34124-34134.
38. Breitschopf K., Haendeler J., Malchow P., Zeiher A.M., Dimmeler S. Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: molecular characterization of the involved signaling pathway. Molecular and Cellular Biology 2000, 20:1886-1896.
39. Niture S.K., Jaiswal A.K. INrf2 (Keap1) targets Bcl-2 degradation and controls cellular apoptosis. Cell Death and Differentiation 2011, 18:439-451.
40. Zhang J., Yan H., Wu Y.P., Li C., Zhang G.Y. Activation of GluR6-containing kainate receptors induces ubiquitin-dependent Bcl-2 degradation via denitrosylation in the rat hippocampus after kainate treatment. Journal of Biological Chemistry 2011, 286:7669-7680.
41. Elhasid R., Sahar D., Merling A., Zivony Y., Rotem A., Ben-Arush M., et al. Mitochondrial pro-apoptotic ARTS protein is lost in the majority of acute lymphoblastic leukemia patients. Oncogene 2004, 23:5468-5475.
42. Gottfried Y., Voldavsky E., Yodko L., Sabo E., Ben-Itzhak O., Larisch S. Expression of the pro-apoptotic protein ARTS in astrocytic tumors: correlation with malignancy grade and survival rate. Cancer 2004, 101:2614-2621.
43. Lotan R., Rotem A., Gonen H., Finberg J.P., Kemeny S., Steller H., et al. Regulation of the proapoptotic ARTS protein by ubiquitin-mediated degradation. Journal of Biological Chemistry 2005, 280:25802-25810.
44. Gottfried Y., Rotem A., Lotan R., Steller H., Larisch S. The mitochondrial ARTS protein promotes apoptosis through targeting XIAP. EMBO Journal 2004, 23:1627-1635.
45. Narendra D., Tanaka A., Suen D.F., Youle R.J. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. Journal of Cell Biology 2008, 183:795-803.
46. Darios F., Corti O., Lucking C.B., Hampe C., Muriel M.P., Abbas N., et al. Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. Human Molecular Genetics 2003, 12:517-526.
47. Berger A.K., Cortese G.P., Amodeo K.D., Weihofen A., Letai A., LaVoie M.J. Parkin selectively alters the intrinsic threshold for mitochondrial cytochrome c release. Human Molecular Genetics 2009, 18:4317-4328.
48. Chen D., Gao F., Li B., Wang H., Xu Y., Zhu C., et al. Parkin mono-ubiquitinates Bcl-2 and regulates autophagy. Journal of Biological Chemistry 2010, 285:38214-38223.
49. Li H., Zhu H., Xu C.J., Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998, 94:491-501.
50. Willis S.N., Adams J.M. Life in the balance: how BH3-only proteins induce apoptosis. Current Opinion in Cell Biology 2005, 17:617-625.
51. Ott M., Norberg E., Zhivotovsky B., Orrenius S. Mitochondrial targeting of tBid/Bax: a role for the TOM complex?. Cell Death and Differentiation 2009, 16:1075-1082.
52. Lovell J.F., Billen L.P., Bindner S., Shamas-Din A., Fradin C., Leber B., et al. Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by Bax. Cell 2008, 135:1074-1084.
53. Goonesinghe A., Mundy E.S., Smith M., Khosravi-Far R., Martinou J.C., Esposti M.D. Pro-apoptotic Bid induces membrane perturbation by inserting selected lysolipids into the bilayer. Biochemical Journal 2005, 387:109-118.
54. Breitschopf K., Zeiher A.M., Dimmeler S. Ubiquitin-mediated degradation of the proapoptotic active form of bid. A functional consequence on apoptosis induction. Journal of Biological Chemistry 2000, 275:21648-21652.
55. Tait S.W., de Vries E., Maas C., Keller A.M., D'Santos C.S., Borst J. Apoptosis induction by Bid requires unconventional ubiquitination and degradation of its N-terminal fragment. Journal of Cell Biology 2007, 179:1453-1466.
56. Azakir B.A., Desrochers G., Angers A. The ubiquitin ligase Itch mediates the antiapoptotic activity of epidermal growth factor by promoting the ubiquitylation and degradation of the truncated C-terminal portion of Bid. FEBS Journal 2010, 277:1319-1330.
57. Fueller J., Becker M., Sienerth A.R., Fischer A., Hotz C., Galmiche A. C-RAF activation promotes BAD poly-ubiquitylation and turn-over by the proteasome. Biochemical and Biophysical Research Communications 2008, 370:552-556.
58. Fukazawa H., Noguchi K., Masumi A., Murakami Y., Uehara Y. BimEL is an important determinant for induction of anoikis sensitivity by mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitors. Molecular Cancer Therapeutics 2004, 3:1281-1288.
59. Thompson S., Pearson A.N., Ashley M.D., Jessick V., Murphy B.M., Gafken P., et al. Identification of a novel Bcl-2-interacting mediator of cell death (Bim) E3 ligase, tripartite motif-containing protein 2 (TRIM2), and its role in rapid ischemic tolerance-induced neuroprotection. Journal of Biological Chemistry 2011, 286:19331-19339.
60. Chinnadurai G., Vijayalingam S., Rashmi R. BIK, the founding member of the BH3-only family proteins: mechanisms of cell death and role in cancer and pathogenic processes. Oncogene 2008, 27(Suppl. 1):S20-S29.
61. Akiyama T., Bouillet P., Miyazaki T., Kadono Y., Chikuda H., Chung U.I., et al. Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim. EMBO Journal 2003, 22:6653-6664.
62. Wang J., Zhou J.Y., Wu G.S. Bim protein degradation contributes to cisplatin resistance. Journal of Biological Chemistry 2011, 286:22384-22392.
63. Wiggins C.M., Tsvetkov P., Johnson M., Joyce C.L., Lamb C.A., Bryant N.J., et al. BIM(EL), an intrinsically disordered protein, is degraded by 20S proteasomes in the absence of poly-ubiquitylation. Journal of Cell Science 2011, 124:969-977.
64. Hinds M.G., Smits C., Fredericks-Short R., Risk J.M., Bailey M., Huang D.C., et al. Bim, Bad and Bmf: intrinsically unstructured BH3-only proteins that undergo a localized conformational change upon binding to prosurvival Bcl-2 targets. Cell Death and Differentiation 2007, 14:128-136.
65. Wright P.E., Dyson H.J. Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. Journal of Molecular Biology 1999, 293:321-331.
66. Tsvetkov P., Reuven N., Shaul Y. The nanny model for IDPs. Nature Chemical Biology 2009, 5:778-781.
67. Hsu S.Y., Kaipia A., McGee E., Lomeli M., Hsueh A.J. Bok is a pro-apoptotic Bcl-2 protein with restricted expression in reproductive tissues and heterodimerizes with selective anti-apoptotic Bcl-2 family members. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:12401-12406.
68. Liu F.T., Agrawal S.G., Gribben J.G., Ye H., Du M.Q., Newland A.C., et al. Bortezomib blocks Bax degradation in malignant B cells during treatment with TRAIL. Blood 2008, 111:2797-2805.
69. Agrawal S.G., Liu F.T., Wiseman C., Shirali S., Liu H., Lillington D., et al. Increased proteasomal degradation of Bax is a common feature of poor prognosis chronic lymphocytic leukemia. Blood 2008, 111:2790-2796.
70. Li B., Dou Q.P. Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:3850-3855.
71. Fu N.Y., Sukumaran S.K., Kerk S.Y., Yu V.C. Baxbeta: a constitutively active human Bax isoform that is under tight regulatory control by the proteasomal degradation mechanism. Molecular Cell 2009, 33:15-29.
72. Benard G., Neutzner A., Peng G., Wang C., Livak F., Youle R.J., et al. IBRDC2, an IBR-type E3 ubiquitin ligase, is a regulatory factor for Bax and apoptosis activation. EMBO Journal 2010, 29:1458-1471.
73. Wolter K.G., Hsu Y.T., Smith C.L., Nechushtan A., Xi X.G., Youle R.J. Movement of Bax from the cytosol to mitochondria during apoptosis. Journal of Cell Biology 1997, 139:1281-1292.
74. Hsu Y.T., Youle R.J. Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations. Journal of Biological Chemistry 1998, 273:10777-10783.
75. Suzuki M., Youle R.J., Tjandra N. Structure of Bax: coregulation of dimer formation and intracellular localization. Cell 2000, 103:645-654.
76. Antonsson B., Montessuit S., Sanchez B., Martinou J.C. Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells. Journal of Biological Chemistry 2001, 276:11615-11623.
77. Ruffolo S.C., Shore G.C. BCL-2 selectively interacts with the BID-induced open conformer of BAK, inhibiting BAK auto-oligomerization. Journal of Biological Chemistry 2003, 278:25039-25045.
78. Tan C., Dlugosz P.J., Peng J., Zhang Z., Lapolla S.M., Plafker S.M., et al. Auto-activation of the apoptosis protein Bax increases mitochondrial membrane permeability and is inhibited by Bcl-2. Journal of Biological Chemistry 2006, 281:14764-14775.
79. Tembe V., Henderson B.R. BARD1 translocation to mitochondria correlates with Bax oligomerization, loss of mitochondrial membrane potential, and apoptosis. Journal of Biological Chemistry 2007, 282:20513-20522.
80. Brodie K.M., Henderson B.R. Differential modulation of BRCA1 and BARD1 nuclear localisation and foci assembly by DNA damage. Cellular Signalling 2010, 22:291-302.
81. Fu N.Y., Sukumaran S.K., Yu V.C. Inhibition of ubiquitin-mediated degradation of MOAP-1 by apoptotic stimuli promotes Bax function in mitochondria. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:10051-10056.
82. Tan K.O., Tan K.M., Chan S.L., Yee K.S., Bevort M., Ang K.C., et al. MAP-1, a novel proapoptotic protein containing a BH3-like motif that associates with Bax through its Bcl-2 homology domains. Journal of Biological Chemistry 2001, 276:2802-2807.
83. Lee S.S., Fu N.Y., Sukumaran S.K., Wan K.F., Wan Q., Yu V.C. TRIM39 is a MOAP-1-binding protein that stabilizes MOAP-1 through inhibition of its poly-ubiquitination process. Experimental Cell Research 2009, 315:1313-1325.
84. Underbrink M.P., Howie H.L., Bedard K.M., Koop J.I., Galloway D.A. E6 proteins from multiple human betapapillomavirus types degrade Bak and protect keratinocytes from apoptosis after UVB irradiation. Journal of Virology 2008, 82:10408-10417.
85. Simmonds M., Storey A. Identification of the regions of the HPV 5 E6 protein involved in Bak degradation and inhibition of apoptosis. International Journal of Cancer 2008, 123:2260-2266.
86. McLaughlin-Drubin M.E., Munger K. Oncogenic activities of human papillomaviruses. Virus Research 2009, 143:195-208.
87. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990, 63:1129-1136.
88. Karbowski M. Mitochondria on guard: role of mitochondrial fusion and fission in the regulation of apoptosis. Advances in Experimental Medicine and Biology 2010, 687:131-142.
89. Chan D.C. Mitochondria: dynamic organelles in disease, aging, and development. Cell 2006, 125:1241-1252.
90. Detmer S.A., Chan D.C. Functions and dysfunctions of mitochondrial dynamics. Nature Reviews Molecular Cell Biology 2007, 8:870-879.
91. Karbowski M., Youle R.J. Dynamics of mitochondrial morphology in healthy cells and during apoptosis. Cell Death and Differentiation 2003, 10:870-880.
92. Suen D.F., Norris K.L., Youle R.J. Mitochondrial dynamics and apoptosis. Genes and Development 2008, 22:1577-1590.
93. Karbowski M., Neutzner A., Youle R.J. The mitochondrial E3 ubiquitin ligase MARCH5 is required for Drp1 dependent mitochondrial division. Journal of Cell Biology 2007, 178:71-84.
94. Nakamura N., Kimura Y., Tokuda M., Honda S., Hirose S. MARCH-V is a novel mitofusin 2- and Drp1-binding protein able to change mitochondrial morphology. EMBO Reports 2006, 7:1019-1022.
95. Yonashiro R., Ishido S., Kyo S., Fukuda T., Goto E., Matsuki Y., et al. A novel mitochondrial ubiquitin ligase plays a critical role in mitochondrial dynamics. EMBO Journal 2006, 25:3618-3626.
96. Zhang B., Huang J., Li H.L., Liu T., Wang Y.Y., Waterman P., et al. GIDE is a mitochondrial E3 ubiquitin ligase that induces apoptosis and slows growth. Cell Research 2008, 18:900-910.
97. Wasiak S., Zunino R., McBride H.M. Bax/Bak promote sumoylation of DRP1 and its stable association with mitochondria during apoptotic cell death. Journal of Cell Biology 2007, 177:439-450.
98. Pahler J.C., Ruiz S., Niemer I., Calvert L.R., Andreeff M., Keating M., et al. Effects of the proteasome inhibitor, bortezomib, on apoptosis in isolated lymphocytes obtained from patients with chronic lymphocytic leukemia. Clinical Cancer Research 2003, 9:4570-4577.
99. Premkumar D.R., Jane E.P., Agostino N.R., Didomenico J.D., Pollack I.F. Bortezomib-induced sensitization of malignant human glioma cells to vorinostat-induced apoptosis depends on reactive oxygen species production, mitochondrial dysfunction, Noxa upregulation, Mcl-1 cleavage, and DNA damage. Molecular Carcinogenesis 2011, http://dx.doi.org/10.1002/mc.21835. [Epub ahead of print].
100. Jana N.R., Dikshit P., Goswami A., Nukina N. Inhibition of proteasomal function by curcumin induces apoptosis through mitochondrial pathway. Journal of Biological Chemistry 2004, 279:11680-11685.
101. Milacic V., Banerjee S., Landis-Piwowar K.R., Sarkar F.H., Majumdar A.P., Dou Q.P. Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo. Cancer Research 2008, 68:7283-7292.
102. Chiu T.L., Su C.C. Curcumin inhibits proliferation and migration by increasing the Bax to Bcl-2 ratio and decreasing NF-kappaBp65 expression in breast cancer MDA-MB-231 cells. International Journal of Molecular Medicine 2009, 23:469-475.
103. Chou J.J., Li H., Salvesen G.S., Yuan J., Wagner G. Solution structure of BID, an intracellular amplifier of apoptotic signaling. Cell 1999, 96(5):615-624.
104. Zha J., Weiler S., Oh K.J., Wei M.C., Korsmeyer S.J. Posttranslational N-myristoylation of BID as a molecular switch for targeting mitochondria and apoptosis. Science 2000, 290(5497):1761-1765.
105. Kuwana T., Mackey M.R., Perkins G., Ellisman M.H., Latterich M., Schneiter R., et al. Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 2002, 111(3):331-342.
106. Tan K.O., Tan K.M., Yu V.C. A novel BH3-like domain in BID is required for intramolecular interaction and autoinhibition of pro-apoptotic activity. Journal of Biological Chemistry 1999, 274(34):23687-23690.
107. Kudla G., Montessuit S., Eskes R., Berrier C., Martinou J.C., Ghazi A. The destabilization of lipid membranes induced by the C-terminal fragment of caspase 8-cleaved bid is inhibited by the N-terminal fragment. Journal of Biological Chemistry 2000, 275(30):22713-22718.
108. Renshaw S.A., Dempsey C.E., Barnes F.A., Bagstaff S.M., Dower S.K., Bingle C.D. Three novel Bid proteins generated by alternative splicing of the human Bid gene. Journal of Biological Chemistry 2004, 279(4):2846-2855.